FI962010A - Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja - Google Patents
Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja Download PDFInfo
- Publication number
- FI962010A FI962010A FI962010A FI962010A FI962010A FI 962010 A FI962010 A FI 962010A FI 962010 A FI962010 A FI 962010A FI 962010 A FI962010 A FI 962010A FI 962010 A FI962010 A FI 962010A
- Authority
- FI
- Finland
- Prior art keywords
- immunosuppressants
- oxo
- nucleosides useful
- nucleosides
- useful
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
- C07D473/18—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 one oxygen and one nitrogen atom, e.g. guanine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Urology & Nephrology (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Reproductive Health (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15108893A | 1993-11-12 | 1993-11-12 | |
PCT/US1994/011778 WO1995013277A1 (en) | 1993-11-12 | 1994-10-13 | 6-oxo-nucleosides useful as immunosuppressants |
Publications (2)
Publication Number | Publication Date |
---|---|
FI962010A0 FI962010A0 (fi) | 1996-05-10 |
FI962010A true FI962010A (fi) | 1996-07-10 |
Family
ID=22537266
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FI962010A FI962010A (fi) | 1993-11-12 | 1996-05-10 | Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0728134A1 (fi) |
JP (1) | JPH09509397A (fi) |
KR (1) | KR960705825A (fi) |
CN (1) | CN1137274A (fi) |
AU (1) | AU677732B2 (fi) |
CA (1) | CA2175897A1 (fi) |
FI (1) | FI962010A (fi) |
HU (1) | HUT74989A (fi) |
IL (1) | IL111544A0 (fi) |
NO (1) | NO961901L (fi) |
WO (1) | WO1995013277A1 (fi) |
ZA (1) | ZA948591B (fi) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU717160B2 (en) * | 1994-06-22 | 2000-03-16 | Shire Canada Inc. | Novel substituted purinyl derivatives with immunomodulating activity |
US5994361A (en) * | 1994-06-22 | 1999-11-30 | Biochem Pharma | Substituted purinyl derivatives with immunomodulating activity |
US6859652B2 (en) | 2000-08-02 | 2005-02-22 | Mobile Satellite Ventures, Lp | Integrated or autonomous system and method of satellite-terrestrial frequency reuse using signal attenuation and/or blockage, dynamic assignment of frequencies and/or hysteresis |
US20110104186A1 (en) | 2004-06-24 | 2011-05-05 | Nicholas Valiante | Small molecule immunopotentiators and assays for their detection |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IN164556B (fi) * | 1986-03-06 | 1989-04-08 | Takeda Chemical Industries Ltd | |
IT1229531B (it) * | 1988-01-20 | 1991-09-04 | Univ Minnesota | Composti nucleosidi dideossidideidrocarbociclici e formulazione farmaceutica che li contiene |
AU647822B2 (en) * | 1990-09-14 | 1994-03-31 | Marion Merrell Dow Inc. | Novel carbocyclic adenosine analogs useful as immunosuppressants |
-
1994
- 1994-10-13 HU HU9601262A patent/HUT74989A/hu unknown
- 1994-10-13 KR KR1019960702453A patent/KR960705825A/ko not_active Application Discontinuation
- 1994-10-13 AU AU81207/94A patent/AU677732B2/en not_active Expired - Fee Related
- 1994-10-13 CA CA002175897A patent/CA2175897A1/en not_active Abandoned
- 1994-10-13 JP JP7513835A patent/JPH09509397A/ja active Pending
- 1994-10-13 CN CN94194463A patent/CN1137274A/zh active Pending
- 1994-10-13 EP EP95900365A patent/EP0728134A1/en not_active Withdrawn
- 1994-10-13 WO PCT/US1994/011778 patent/WO1995013277A1/en not_active Application Discontinuation
- 1994-11-01 ZA ZA948591A patent/ZA948591B/xx unknown
- 1994-11-07 IL IL11154494A patent/IL111544A0/xx unknown
-
1996
- 1996-05-10 FI FI962010A patent/FI962010A/fi not_active Application Discontinuation
- 1996-05-10 NO NO961901A patent/NO961901L/no unknown
Also Published As
Publication number | Publication date |
---|---|
HU9601262D0 (en) | 1996-07-29 |
WO1995013277A1 (en) | 1995-05-18 |
NO961901L (no) | 1996-07-11 |
AU8120794A (en) | 1995-05-29 |
ZA948591B (en) | 1995-06-23 |
NO961901D0 (no) | 1996-05-10 |
CN1137274A (zh) | 1996-12-04 |
HUT74989A (en) | 1997-03-28 |
IL111544A0 (en) | 1995-01-24 |
KR960705825A (ko) | 1996-11-08 |
CA2175897A1 (en) | 1995-05-18 |
FI962010A0 (fi) | 1996-05-10 |
AU677732B2 (en) | 1997-05-01 |
EP0728134A1 (en) | 1996-08-28 |
JPH09509397A (ja) | 1997-09-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI931229A0 (fi) | Som glanspigment laempade blandningar | |
FI933167A (fi) | N-alkylkinuklidiniumsalter som substans-p antagonister | |
FI934568A0 (fi) | Hydrofobisitet som aostadkommits med metalljonaktivering | |
FI921182A (fi) | Velangummi som snabbt hydratiseras | |
FI931069A0 (fi) | Kolloidalt rostat kaffe som aromatiseringsprodukt | |
FI933022A0 (fi) | Radiosystem som bildar en traodloes lokalslinga | |
FI934751A0 (fi) | Extracellulaera matrisreceptorligander som modulerar leukocytfunktioner | |
FI932094A0 (fi) | Kylningsapparat i kranens vaexel | |
FI932732A0 (fi) | Rotorkonstruktion i en tvaolindningselektricitetsmaskin | |
FI932264A0 (fi) | Gapformare i en pappersmaskin | |
FI962010A (fi) | Immuunivastetta heikentävinä aineina käytettäviä 6-okso-nukleosideja | |
FI930342A0 (fi) | Pentapeptider som reglerar immun- och nervsystem | |
FI935826A0 (fi) | Kallsmoerjmedel med delvis neutraliserade fosforsyraestrar som EP-tillsatsaemnen | |
FI930927A0 (fi) | Banformningsparti i en pappersmaskin | |
FI930528A0 (fi) | Luftkuddskonstruktion som passagerarskydd i fordon | |
FI810U1 (fi) | Staell som underlaettar mattvaett | |
FI934401A0 (fi) | Lufttillfoerselsystem som hindrar milfoerbraenning | |
FI930018A0 (fi) | Staell som underlaettar mattvaett | |
FI931598A0 (fi) | Spelbraede foer som bokstavplattor formade spelbrickor | |
FI933315A0 (fi) | Anordning som underlaettar plockning av jordgubbar | |
FI932312A0 (fi) | Anordning som underlaettar borstning av taender | |
FI934219A0 (fi) | Foerbandsbalkkonstruktion som huvudsaklig baerare foer mellanbjaelklag i flervaeningshus (tt-foerbandsbalk) | |
FI935925A0 (fi) | Fortskaffningsmedel som utfoer tvaofasroerelse med hjaelp av en ledemekanism | |
FI933314A0 (fi) | Foerfarande foer framstaellning av fiberspaon som raomaterial till en starkpapperssort | |
FI933281A0 (fi) | Hydrauliskt stoetdaempningssystem som alstrar elektricitet |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD | Application lapsed |